Drug Trial Radar · NCT05718375
Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria
Last checked: Nov 19, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
240
Actual
Start
Feb 14, 2023
Primary completion
Nov 12, 2025
Study completion Nov 12, 2025
Sponsor
- Lead sponsor
- Curacle Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 8, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of CU01-1001 administered for 24 weeks in type 2 diabetic nephropathy patients with albuminuria.
Conditions
- Diabetic Nephropathies
Interventions
CU01-1001Drug
CU01-1001
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change rate of urinary albumin/creatinine ratio (UACR) at 24 weeks compared to baselineTime frame: Day 0, 24 weeks
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Pusan National University Hospital
Busan, South Korea
SoonChunHyang University Hospital Cheonan
Chuncheon, South Korea
Daegu Catholic University Medical Center
Daegu, South Korea
Keimyung University Dongsan Hospital
Daegu, South Korea
Kyungpook National University Chilgok Hospital
Daegu, South Korea
Yeongnam University Medical Center
Daegu, South Korea
Daejeon Eulji Medical Center, Eulji University
Daejeon, South Korea
Ajou University Hospital
Gyeonggi-do, South Korea
Hallym University Dongtan Sacred Heart Hospital
Gyeonggi-do, South Korea
Korea University Ansan Hospital
Gyeonggi-do, South Korea
Seoul National University Bundang Hospital
Gyeonggi-do, South Korea
The Catholic University of Korea Bucheon St. Mary's Hospital
Gyeonggi-do, South Korea
Gachon University Gil Medical Center
Incheon, South Korea
Jeonbuk National University Hospital
Jeonju, South Korea
Hallym University Gangnam Sacred Heart Hospital
Seoul, South Korea
Kangbuk Samsung Hospital
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
Kyung Hee University Hospital
Seoul, South Korea
Nowon Eulji University
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Severance Hospital
Seoul, South Korea
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, South Korea
Wonju Severance Christian Hospital
Wŏnju, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.